Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California. The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha. As of 2013, the company had 83 employees. OncoMed's drug discovery work focuses on developing "targeted…
History, Art & Companies
Explore the main themes, entities and connections around OncoMed. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
company 2013 cancer stem public university michigan nasdaq california two oncomed's redwood city founded michael clarke max wicha american development
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| OncoMed | Defunct | April 23, 2019 (2019-04-23) | 1.00 | infobox |
| OncoMed | Fate | Acquired by Mereo BioPharma | 1.00 | infobox |
| OncoMed | Founded | University of Michigan | 1.00 | infobox |
| OncoMed | Founders | Michael Clarke | 1.00 | infobox |
| OncoMed | Founders | Max Wicha | 1.00 | infobox |
| OncoMed | Headquarters | Redwood City, California, United States | 1.00 | infobox |
| OncoMed | Industry | Pharmaceutical | 1.00 | infobox |
| OncoMed | Key people | Paul Hastings (CEO) | 1.00 | infobox |
| OncoMed | Key people | John Lewicki (R&D chief) | 1.00 | infobox |
| OncoMed | Key people | Chuck Alaimo (Operations director) | 1.00 | infobox |
| OncoMed | Number of employees | 83 (2013) | 1.00 | infobox |
| OncoMed | Number of employees | 47 (2007) | 1.00 | infobox |
| OncoMed | Revenue | US$24,700,000 (2012) | 1.00 | infobox |
| OncoMed | Total assets | US$207,600,000 (2016) | 1.00 | infobox |
| OncoMed | Traded as | Nasdaq: OMED | 1.00 | infobox |
| OncoMed | Type | Private (2004-13) Public (2013-19) | 1.00 | infobox |
| OncoMed | is a | best positioned of the three companies focused on the cancer stem cell area | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.